PGEN Intrexon: Earnings per share for the last twelve months
Precigen, Inc. (PGEN) is implementing rapid UltraCAR-T gene therapy production to optimize clinics. Tracking the TTM net income per share slice on GURU.Markets, we note that the current mark is 0.04. Intellectual property monetization is based on licenses for pharma behemoths, while operational stability is maintained through strict agreements with viral vector vendors.
Analytical breakdowns and data insights for company Precigen Inc (PGEN)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Precigen, Inc.|PGEN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Intrexon|PGEN - Company Aggregate Indebtedness|Debt to Book Capitalization Ratio Precigen, Inc.|PGEN - Company Long-Term Loans and Borrowings|Company Short-Term Debts Precigen|Quick Ratio precigen.com
- earnings and valuation multiples indicators:
PGEN - Net Income|Projected Future Earnings Precigen, Inc.|PGEN - Business Payback Period|Forward P/E Multiple Precigen|PGEN - Price to Net Income Growth Ratio|EV/EBITDA Multiple Precigen, Inc.|PGEN - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Precigen|PGEN - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months precigen.com|PGEN - Earnings per share increase in current year|Earnings growth forecast for next year Precigen, Inc.
- sales and revenue data:
Summary company analysis:PGEN - Precigen, Inc.
Developing breakthrough immunological platforms to combat cancer requires colossal investments, which directly impacts the current profitability of Precigen, Inc. (PGEN). Analyzing the annual net income per share trend allows an investor to see the bottom line divided by the total number of securities, making it possible to assess the real efficiency of the business and its resilience to equity dilution during periods of active growth.
Competing companies
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|AUPH - Earnings per share for the last twelve months|Earnings per one share for the last 12 months BCRX|Vera Therapeutics, Inc. (VERA) - Earnings per share for the last twelve months|dianthustx.com - Earnings per share for the trailing year|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AbCellera Biologics Inc ABCL|Net earnings per share (EPS TTM) TRML|Net earnings per share for the last 12 months Pharming Corp PHAR|Net earnings per share (EPS TTM) NKTR (Nektar Therapeutics)|Net earnings per share for the last four quarters upstreambio.com (UPB)|Zenas Biopharma - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Immunome Inc (IMNM)|GOSS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months KalVista Corp (KALV)|Earnings per share for the last twelve months Septerna Inc|Earnings per share for the last 12 months PVLA (pieris.com)|Net earnings per share for the last 12 months SVRA (Savara)|RIGL (Rigel Pharma) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ANAB (AnaptysBio Corp)|Net earnings per share for the last four quarters Astria Corp (ATXS)|ENGN - Earnings per share for the last twelve months|RAPT (RAPT Therapeutics Inc.) - Earnings per share for the last 12 months|JBIO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Aclaris Therapeutics Inc.|Net earnings per share for the last 12 months KYTX|Tiziana Life Sciences, Ltd. (TLSA) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cabaletta Bio, Inc. (CABA)|VTYX: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) THTX (Theratechnologies)|Net earnings per share for the trailing year Avalo Therapeutics, Inc.|Eledon - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Agenus, Inc|Climb Bio Inc (CLYM) - Earnings per share for the last twelve months|Earnings per share for the last 12 months ZURA|Earnings per share for the last twelve months aTyr Pharma|Adagene Corp - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) IMA|STTK (shattucklabs.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) EQ (Equillium)|Net earnings per share (EPS TTM) Connect Biopharma Holdings CNTB|IMUX - Earnings per share for the last twelve months|Earnings per share for the trailing year ATRA (Atara Biotherapeutics)|inflarx.de (IFRX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months X4 Pharmaceuticals, Inc|ACET (Adicet Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Celularity Corp|Net earnings per share for the last 12 months INMB (INmune Bio)|BRNS (Barinthus Biotherapeutics PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) KZR (Kezar Life Sciences, Inc)|Net earnings per share for the last four quarters SAB Biotherapeutics Inc (SABS)|AKTX - Earnings per share for the last twelve months|Enlivex Therapeutics (ENLV) - Net earnings per share for the last 12 months|q32bio.com (QTTB) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months GeoVax Labs|Net earnings per share for the last 12 months EDSA|Net earnings per share (EPS TTM) iBio Corporation|Earnings per share for the last twelve months Carisma Therapeutics (CARM)|xtlbio.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. (HCWB) - Net earnings per one share for the last twelve months|APVO - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AIM|aditxt.com (ADTX) - Earnings per share for the last twelve months|gribio.com - Earnings per share for the trailing year|XRTX (XORTX Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Vyome Holdings Inc. HIND|Net earnings per share (EPS TTM) REVB|Net earnings per share for the last 12 months Indaptus Corp INDP|Net earnings per share (EPS TTM) SCNI (Scinai Immunotherapeutics)|Net earnings per share for the last four quarters CalciMedica Inc (CALI)|Affimed Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Allakos Inc. (ALLK)|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences (IGMS)|Earnings per share for the last twelve months iTeos Therapeutics|Earnings per share for the last 12 months OCEA (oceanbiomedical.com)|Net earnings per share for the last 12 months TCBP (TC BioPharm)|THRD (Third Harmonic Bio Inc.) - Earnings per share for the trailing year
